Search results
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
Zacks via Yahoo Finance· 12 hours agoThe late-stage study will evaluate AbbVie's (ABBV) experimental antibody to treat patients with...
... Meeting on Clinical Data of First-in-Class anti-CLDN18.2/CD3 Bispecific Antibody (IBI389) for...
Tehachapi News· 4 days ago...01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, delivered two oral presentations of its first-in-class...
AbbVie treats first subject in Phase III multiple myeloma drug trial
Clinical Trials Arena via Yahoo Finance· 19 hours agoABBV-383 is a bispecific antibody T-cell engager that binds to both BCMA and CD3, designed to target...
A culture method with berbamine, a plant alkaloid, enhances CAR-T cell efficacy through modulating...
Nature· 3 days agoWhen used in CAR-T cell processing, the plant alkaloid berbamine prolongs the survival of leukemic animals by boosting CAR-T cell viability, memory phenotype, and persistence by modulating cellular metabolism, including mitochondrial respiration.
Six GOP candidates vie for CD3 nomination
The Daily Sentinel· 5 days agoWhile all six have their own conservative credentials, not all have been viewed equally, including when it comes to financial support. Grand Junction...
Lilly details MASH data for tirzepatide; Cytokinetics comments on past sale talks
BioPharma Dive via Yahoo Finance· 2 days agoA study abstract shed more light on tirzepatide’s potential in MASH. Elsewhere, Cytokinetics CEO...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 7 days agoU.S. FDA ACKNOWLEDGES ASTELLAS' RESUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR ZOLBETUXIMAB AND SETS NEW ACTION DATE PR Newswire TOKYO, May 30, 2024 If approved, the investigational therapy would offer a new treatment option for patients with
Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer...
Nature· 7 days agoEthical approval to generate patient-derived models was obtained through the Tracking Cancer Evolution through Therapy (TRACERx) clinical study (REC reference: 13/LO/1546; https://clinicaltrials.gov ...
Advances in CAR T-Cell Therapy for Multiple Myeloma
MedPage Today· 7 days agoB-cell maturation antigen (BCMA)-directed CAR T-cell therapies are now established options for treating multiple myeloma after relapse, but efforts are...
Nevadans react to Biden’s executive order on the border
KLAS articles via Yahoo News· 2 days agoReaction in Nevada on Tuesday to President Joe Biden's executive order on the U.S.-Mexico border...
